DSB 2003 Program

Session 1: Genetic origins of disease
Steven Petrou, Bionomics: Ion XTM drug discovery program: Opening a new window on ion channel function and drug discovery
Nick Martin, QIMR: Genetic Epidemiology
Simon Easteal, ANU: Genome Diversity and Disease

Session 2: Functional Genomics
Andrew Fraser, Sanger Institute, Cambridg: Genome-wide functional genomics using RNAi
Geoff Symonds, Johnson & Johnson: Ribozymes
Chris Wraight, Antisense Therapeutics: Antisense strategies

Session 3: Innovation - Commercialisation
Craig Lawn, PricewaterhouseCoopers: Commercialising innovation
Matt McNamara, SciCapital: Funding early stage projects
Jonathan Izant, Garvan: Innovative Business Strategies for Discovery Research

Session 4: Proteomics
Robin Anders, La Trobe, CRC Vaccine Technology: From protein structure to vaccine
Ian Smith, Baker Institute: Beyond the Spot: High Throughput Automated Proteomics
Michael Foley, La Trobe: Phage display in diagnostics and vaccine development
Jenny Harry, Proteome Systems: Using proteomics to drive discovery of new biomarkers, diagnostics and drug targets

Session 5: Advances in Genomics
Deon Venter, MCRI: Arrays and expression profiling
Rohan Teasdale, IMB: Reverse Transfection
Hamish Scott, WEHI: A molecular atlas of developing, adult and diseased brains defined using serial analysis of gene expression (SAGE)
Stephen Wilcox, AGRF: Using DNA Microarrays for SNP detection 
Robert Henke, Millennium: NewArray-based tools for whole genome analysis

Session 6: SNPs in gene discovery and personalised medicine
Jeff Thornton, Sequenom: Genome-wide SNP Association for Complex Disease Gene Discovery and Molecular Diagnosis
Jeremy Jowett, International Diabetes Institute: Discovery and Validation of Disease Related Genes using Differential Expression and SNP Genotyping
Karl Poetter, Genera Biosystems: Sequence Identification Flow Test for genetic diagnosis
Garry King, UNSW: Some new tools for personalized medicine - electrotides, proofreading SBE, BVML and captamers

Session 7: Stem cell biotechnology
Alan Colman, ES-Cell International, Singapore: Prospects of stem cell therapy in diabetes
Helen Cooper, University of Queensland: Gene expression in adult neural stem cell development
Rosanne Taylor, University of Sydney: Neural repair with stem cells
Alan Mackay-Sim, Griffith University: Therapeutic use of olfactory stem cells

Conference Committee

May 15-16, 2003, Dockside, Cockle Bay Wharf, Sydney, Australia

Convenor
Professor Keith Stanley,
Centre for Immunology, St Vincents Hospital, Darlinghurst.